Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.12
-0.16 (-1.30%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Medifast Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
71.9189.390.9394.4487.69104.18
Short-Term Investments
97.9177.9771.4255.6-5.36
Cash & Short-Term Investments
169.82167.27162.34150.0487.69109.54
Cash Growth
4.39%3.04%8.20%71.10%-19.95%-37.21%
Inventory
21.1820.2342.4254.59118.86180.04
Other Current Assets
11.0314.189.6419.416.2417.28
Total Current Assets
202.03201.68214.4224.03222.78306.87
Net Property, Plant & Equipment
52.2938.4648.6867.1175.6580.59
Other Long-Term Assets
6.077.8321.1318.7717.7810.87
Total Assets
260.4247.97284.21309.91316.21398.33
Accounts Payable
36.4138.3656.4986.42134.69163.31
Current Portion of Leases
5.164.66.185.895.786.52
Other Current Liabilities
--1.49-0.43-
Total Current Liabilities
41.5642.9664.1692.3140.89169.83
Long-Term Leases
22.466.099.9416.1320.2826.02
Total Long-Term Liabilities
22.466.099.9416.1320.2826.02
Total Liabilities
64.0249.0574.1108.43161.17195.85
Common Stock
0.010.010.010.010.010.01
Treasury Stock
-----6.4-
Additional Paid-in Capital
43.3140.4133.1426.5721.5612.02
Accumulated Other Comprehensive Income
0.010.230.180.250.020.11
Retained Earnings
153.05158.27176.78174.65139.85190.33
Shareholders' Equity
196.38198.92210.11201.48155.04202.47
Total Liabilities & Equity
260.4247.97284.21309.91316.21398.33
Total Debt
27.6210.6916.1322.0126.0532.54
Net Cash (Debt)
142.2156.58146.22128.0361.6477
Net Cash Growth
-4.95%7.08%14.21%107.70%-19.95%-52.85%
Net Cash Per Share
12.8914.2613.3411.725.476.52
Book Value
196.38198.92210.11201.48155.04202.47
Book Value Per Share
17.8018.1119.1718.4513.7517.14
Tangible Book Value
196.38198.92210.11201.48155.04202.47
Tangible Book Value Per Share
17.8018.1119.1718.4513.7517.14
SEC Filings: 10-K · 10-Q